News - Cyclica | Page 6

News

China’s Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19

March 5, 2020 9:00 am

Cyclica and AUM Biosciences to Partner on Developing Novel Cancer Therapies with Greater Precision and Speed, under Project Nexus

January 15, 2020 9:00 am

Translational Medicine Accelerator and Cyclica Partner to Form Rare Diseases Medicine Accelerator to Advance the Discovery of Novel Therapies for Rare Diseases

January 8, 2020 9:00 am

In an Industry Shake Up, Cyclica Announces the Addition of Dr. Melissa Landon, former Director of Applications Science at Schrödinger, as VP, Chief Strategist

January 1, 2020 9:00 am

ATAI Life Sciences and Cyclica Launch Joint Venture to Revolutionize Drug Development for Mental Health Disorders

November 11, 2019 9:00 am

South Korean Company, Yuhan Pharmaceuticals Partners with Cyclica to Advance R&D Across Two Separate Programs for Oncology

November 7, 2019 9:00 am

Cyclica Collaborates With Enamine to Use REAL Technology in Its Ligand Design Platform for AI-augmented Drug Design

November 5, 2019 9:00 am

To Build Stronger Partnerships Globally, Cyclica Appoints Long Time Pharma R&D Leader Vern De Biasi as VP, Global Head of Strategic Partnerships

October 8, 2019 9:00 am

Want to read more about our work?

Check out our blog for perspective pieces on the industry, educational campaigns, employee spotlights, and more.